| |
| |
Caption: Board of Trustees Minutes - 1958
This is a reduced-resolution page image for fast online browsing.
EXTRACTED TEXT FROM PAGE:
1038 BOARD OF TRUSTEES [December 17 238. Ames Research Laboratories, Elkhart, Indiana: to the Department of Clinical Science for a study of choleretic action of various synthetic chemical compounds compared with decholin, under the supervision of Dr. Andrew C. Ivy 239. A r m o u r Laboratories, Kankakee, Illinois: to the Department of Pharmacology for travel expenses for scientists who are invited to conduct seminars for the department 240. Bauer and Black, Chicago: to the Department of Clinical Science for a study of cholesterol synthesis in rats, under the direction of Dr. Andrew C. Ivy 241. Baxter Laboratories, Chicago: to the Department of Microbiology for research on the evaluation of potential chemotherapeutic agents, under the direction of Dr. George H . Scherr 242. Ciba Pharmaceutical Products, Inc., Summit, New Jersey: to the Department of Anatomy for a study of reserpine stress responses, under the direction of Dr. Samuel R. M. Reynolds 243. Dome Chemicals, Inc., New York, New York: to the Department of Dermatology for research under the direction of Dr. Marcus R. Caro 244. E and J Manufacturing Company, Burbank, California: to the Department of Clinical Science to supplement a previous grant to cover expenses for an exhibit on cardio-respiratory dynamics of controlled respiration prepared for the American Medical Association convention, under the direction of Dr. Archer S. Gordon 245. Geigy Pharmaceuticals, Ardsley, New York: to the Department of Pharmacology for a study of action of autonomic drugs on the central nervous system, under the direction of Dr. Klaus R. W. Unna 246. Hoffman-LaRoche, Inc., Nutley, New Jersey T o the Department of Surgery (Anesthesiology) for a study of the comparative evaluation of pentobarbital and noludar, under the supervision of Dr. Max S. Sadove and Dr. Reuben C. Balagot $ 2 000 00 T o the Department of Clinical Science for a study of the effect of marsilid on gastric secretion in dog, under the direction of Dr. Andrew C. Ivy I 553 50 247. Lederle Laboratories, Pearl River, New York: to the Graduate College for fellowships for medical students, under the supervision of Dr. Milan V. Novak 248. EH Lilly and Company, Indianapolis, Indiana To the College of Medicine for research on protein synthesis in virus infections, under the direction of Dr. John E. Kempf $ 5 290 00 T o the Department of Clinical Science for an exploratory study of the effect of phenaglycodal (ultran) on gastric secretion, under the direction of Dr. Andrew C. Ivy 298 75 249. Mead-Johnson and Company, Chicago: to the Department of Pediatrics for pediatric residents, under the direction of Dr. Heyworth N . Sanford 250. Organon, Inc., Orange, New Jersey: to the Department of Physiology for an investigation of properties of a new hypertensive agent, under the direction of Dr. George E. Wakerlin 251. Chas. F . Pfizer and Company, Inc., Brooklyn, New York: to the Department of Medicine for work of investigative nature in infectious diseases and related fields, under the direction of Dr. H a r r y F. Dowling 252. Sandoz Pharmaceuticals, Chicago T o the Department of Pharmacology for the neuropharmacology research fund, under the direction of Dr. Klaus R. W . Unna $ 3 000 00 T o the Department of Medicine to support student assistants for studies in experimental and clinical allergy, under the supervision of Dr. M a x Samter 3 000 00 2 533 35 500 00 I 050 00 774 90 900 00 500 00 873 00 7 315 00 3 553 50 2 400 00 5 588 75 500 00 500 00 600000 8 925 00
| |
